Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methyl-qPCR for EBV-PTLD Prediction
NCT03343834Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2017
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Respective percentages of latent versus replicative EBV profiles at 12 months. Started Dec 2017; status: completed.
Beyond the preview
Go deeper on NCT03343834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03343834.